MarketInOut Stock Screener Log In | Sign Up
 

Pfizer Inc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 05/05/2026 16:00
Pfizer Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization148,779 mln
Float5,679 mln
Earnings Date05/05/2026

EPS

1.36
Moderate

P / E

19.45
Moderately valued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.31
Borderline

1-Year Forecast

29.00
Modest upside

Relative Strength

18 / 100
Significantly lagging

Business Description

Pfizer is one of the world's largest pharmaceutical companies, researching, producing, and selling a wide range of medicines and vaccines across the United States and globally. Its portfolio spans treatments for heart disease, migraines, cancer, rare genetic conditions, infections, and immune disorders, along with preventive vaccines for diseases such as COVID-19 and meningitis. The company also sells biosimilar medicines and works alongside several major partners to develop new therapies, including cutting-edge AI-driven tools for drug discovery. Founded in 1849 and based in New York City, Pfizer remains one of the most recognized names in healthcare worldwide.

Key Fundamentals

EPS1.36
P/E19.45
ROE8.70
RPS10.95
ROIC9.11
ROA3.72
Interest Cover6.52
EBITDA, mln16,784
EV / EBITDA11.93
EV / EBIT19.65
Revenue, mln62,579
EV / Revenue3.20

Financial Strength

Altman Z-Score2.01
Piotroski F-Score 6 / 9
Beneish M-Score-2.31
Price to Intrinsic Value0.61
1-Year Target Price29.00
Shiller PE Ratio9.30
Short Ratio3.45
Short % of Float2.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.11% 34 / 100   
1 Month -4.96% 10 / 100   
2 Months -0.19% 37 / 100   
6 Months 11.04% 65 / 100   
1 Year 17.24% 49 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us